» Articles » PMID: 27752465

Pulmonary Tuberculosis Followed by Sarcoidosis in an HIV-infected Patient: A Case Report and a Simplified Diagnostic Flowchart for Diagnosis and Treatment of Sarcoidosis

Overview
Date 2016 Oct 19
PMID 27752465
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis of sarcoidosis in a patient living with HIV infection is an uncommon event and a challenge for clinicians. Clinical manifestations are variable and fluctuating depending to adherence to ARV therapy and to the level of CD4 count. We analyze here one chronic case in which sarcoidosis appeared clinically two years after pulmonary tuberculosis. The course of the disease was influenced and prolonged by frequent interruptions of antiretroviral therapy. Moreover the diagnosis and the decision to treat have been delayed by the need of exclusion of other pathologies, principally tuberculosis reactivation/reinfection, other mycobacterial diseases, hematologic malignancies. We propose a simplified flowchart for diagnosis and follow up of sarcoidosis, which may also be applied to patients with HIV infection. Diagnosis of latent tuberculosis infection (LTBI) may be difficult in these patients, because the immunological paradox of sarcoidosis. For this reason, following exclusion of active tuberculosis, we advise to submit all sarcoidosis patients to IPT (isoniazid preventive therapy), when immunosuppressive therapy is started.

Citing Articles

Lymphadenopathy and granulomas: benignancy of malignancy and differential diagnosis with endobronchial ultrasound-transbronchial needle biopsy 19G needle fine-needle aspiration biopsy.

Zarogoulidis P, Hatzibougias D, Tsakiridis K, Matthaios D, Hohenforst-Schmidt W, Huang H Lung Cancer Manag. 2021; 10(3):LMT49.

PMID: 34408790 PMC: 8369527. DOI: 10.2217/lmt-2021-0002.


The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients.

Abedini A, Naderi Z, Kiani A, Marjani M, Mortaz E, Ghorbani F J Res Med Sci. 2020; 25:24.

PMID: 32419781 PMC: 7213005. DOI: 10.4103/jrms.JRMS_74_19.

References
1.
Doffman S, Miller R . Interstitial lung disease in HIV. Clin Chest Med. 2013; 34(2):293-306. DOI: 10.1016/j.ccm.2013.01.012. View

2.
Scadding J . Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961; 2(5261):1165-72. PMC: 1970202. DOI: 10.1136/bmj.2.5261.1165. View

3.
Badgwell C, Rosen T . Cutaneous sarcoidosis therapy updated. J Am Acad Dermatol. 2006; 56(1):69-83. DOI: 10.1016/j.jaad.2006.06.019. View

4.
Brownell I, Ramirez-Valle F, Sanchez M, Prystowsky S . Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol. 2011; 45(5):899-905. PMC: 3361363. DOI: 10.1165/rcmb.2010-0433TR. View

5.
Kantrow S, Meyer K, Kidd P, Raghu G . The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1998; 10(12):2716-21. DOI: 10.1183/09031936.97.10122716. View